Longevity Health Holdings, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Longevity Health Holdings, Inc. (XAGE) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $329.01 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-31
- Longevity Health Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $329.01K, a 92.42% decline from fiscal 2024.
- Longevity Health Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $4.34M.
- Longevity Health Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was -$2.20M.
- Longevity Health Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was -$2.32M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 11 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $329.01K 10-K · filed 2026-03-31 | ||
| 2024-12-31 | $4.34M 10-K · filed 2026-03-31 | -$4.34M 10-K · filed 2025-03-31 | |
| 2023-12-31 | -$2.20M 10-K/A · filed 2025-06-17 | ||
| 2022-12-31 | -$2.32M 10-K · filed 2024-04-01 | -$266.00K 10-K · filed 2023-03-17 | |
| 2021-12-31 | -$96.46K 10-K · filed 2023-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |